Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | -1.02% | -2.51% | -2.02% |
Sales 2024 * | 20.8M 1.66B | Sales 2025 * | 19.22M 1.53B | Capitalization | 158M 12.6B |
---|---|---|---|---|---|
Net income 2024 * | -39M -3.11B | Net income 2025 * | -34M -2.71B | EV / Sales 2024 * | 7.59 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.21 x |
P/E ratio 2024 * |
-4.36
x | P/E ratio 2025 * |
-4.73
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.34% |
Latest transcript on ProQR Therapeutics N.V.
1 day | -1.02% | ||
1 week | -2.51% | ||
Current month | -15.28% | ||
1 month | -15.28% | ||
3 months | -6.73% | ||
6 months | +65.81% | ||
Current year | -2.02% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel de Boer
CEO | Chief Executive Officer | 41 | 20/02/12 |
Founder | 60 | 20/02/12 | |
Jurriaan Dekkers
DFI | Director of Finance/CFO | - | 30/09/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Domenico Valerio
FOU | Founder | 67 | 20/02/12 |
Founder | 60 | 20/02/12 | |
Alison Lawton
BRD | Director/Board Member | 62 | 16/09/14 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.94 | -1.02% | 50,793 |
25/04/24 | 1.96 | -2.49% | 238,956 |
24/04/24 | 2.01 | -0.50% | 36,411 |
23/04/24 | 2.02 | +1.00% | 185,505 |
22/04/24 | 2 | +0.50% | 113,304 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.02% | 158M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PRQR Stock